- freely available
Molecules 2014, 19(1), 149-158; doi:10.3390/molecules19010149
Published: 23 December 2013
Abstract: Fibronectin adsorption on biomaterial surfaces plays a key role in the biocompatibility of biomedical implants. In the current study, the adsorption behavior of the 7–10th type III modules of fibronectin (FN-III7–10) in the presence of hydroxyapatite (HAP) was systematically investigated by using molecular docking approach. It was revealed that the FN-III10 is the most important module among FN-III7–10 in promoting fibronectin binding to HAP by optimizing the interaction energy; the arginine residues were observed to directly interact with the hydroxyl group of HAP through electrostatic forces and hydrogen bonding. Moreover, it was found that the HAP-binding sites on FN-III10 are mainly located at the RGD loop region, which does not affect the interaction between the fibronectin protein and its cognate receptors on the cell surface.
Fibronectin (FN) is a prominent component of extracellular matrices (ECM) and is present at high concentrations (~300 mg/mL) in plasma. It is composed of three types of repeating modules, termed type I, II and III repeats, which are organized into functional domains [1,2,3]. FN mediates its biological effects through binding to the hetero-dimeric transmembrane glycoproteins, integrins, which physically couple the cytoskeleton to the ECM . A majority of integrin-mediated interactions of FN with cells occur through the cell binding triplet Arg-Gly-Asp (RGD loop). Disruption of the FN gene results in an embryonic lethal phenotype, confirming the importance of FN in the cellular development  and synthetic RGD loop inhibits cell adhesion on FN coated substrates , confirming the importance of RGD loop in the function of FN.
Hydroxyapatite (HAP, [Ca10(PO4)(OH)2]), which is the most abundant apatite in human bone and often considered as “the golden standard” in orthopedics , exhibits a desirable bone-tissue response as compared to bare metal implants, including absence of intervening fibrous tissue between bone and implant, lack of inflammation, and strong binding to bone . However, the detailed mechanism underlying this biocompatibility is still not fully understood. The biocompatibility of an implant is related to how the adhering cells interact with the implant surface when the implant is inserted into the body . These cellular responses are in turn influenced by proteins adsorbing on the implant from the body fluids. Accordingly, the arriving cells sense the protein layer covering the surface when they arrive on that surface, thereby “seeing” the implant surface properties through the protein layer . The cellular response therefore depends on the detailed properties of the resulting interfacial protein layer, among which FN is the key one that not only provides a substrate for cell anchorage, but also serves as a regulatory protein in processes such as cell adhesion, motility and proliferation [11,12,13,14,15].
Numerous experimental methods have been developed to investigate the protein adsorption with HA, and researchers have studied the adsorption of proteins on the surface of biomaterials by the methods such as atomic force microscopy (AFM) , flow microcalorimetry (FMC) , solid state NMR , 2D electrophoresis , and steered molecular dynamics (SMD) simulations . In this work, the interaction mechanism of FN-III7–10, which contains the RGD loop, with HAP molecules was investigated systematically by using a molecular docking strategy. All the binding sites and the binding energy were studied to explore the structural basis and energetic properties of the interactions between FN-III7–10 and HAP. Moreover, the binding sites in the RGD loop region of FNIII10 and the influence of FNIII10 on the binding of other modules to HAP were also characterized in detail for its great importance in promoting cell adsorption.
2. Results and Discussion
2.1. Identification of Potential HAP-Binding Sites on FN-III7–10 Surface and Molecular Docking of HAP to FN
The protein surface can form pockets that are potential binding sites of small-molecule ligands. Therefore, the identification of pocket sites on the protein surface is often the starting point for protein function annotation and structure-based analysis . Also, proper ligand-binding site detection is a prerequisite for protein–ligand docking. Over the past decades, many computational methods have been developed to predict protein–ligand binding sites based on detection of cavities on protein surface. Here, MPK2 was employed to predict the pockets in different fragments of FN, and the results are shown in Figure 1. The predicted pockets are consistent by different methods at the same fragments, and most high scorning pockets exist in the FN-III10 fragment and the hinge areas of different modules of FN.
The binding sites and interaction free energies between the FN-III7–10 and HAP were further examined using the tool suite of AutoDock 4 . Both the ligand and the receptor were treated as rigid and we only explored the six degrees of translational and rotational freedom, hence excluding any kind of flexibility. There were multiple binding sites detected at every binding cluster and ten sites of minimum binding energy were selected. The resulting binding sites are shown in Figure 2. A total of 13 predicted binding clusters in FN-III7–10 were detected, which separately locate at the FN-III8, FN-III9, FN-III10 and the hinge region. While the sites with the lowest binding energy were in FN-III10, and there were no sites found in FN-III7. All the results were consistent with the results predicted by MPK2. For each binding cluster, the sites of the lowest binding energy were further investigated with respect to their interacting amino acids. The residues Arg1493, Arg1445, Gly1494, Lys1324, Arg1403, Arg1371, Phe1366, Ser1367 and Gly1368 were from cluster 1–4 (Figure 3), which formed the lowest binding energy sites in all clusters. Arginine is the most important amino acid in the binding of HAP to FN with the highest frequency of occurrence. The side chain of arginine consists of a 3-carbon aliphatic straight chain, and the distal end of which is capped by a complex guanidinium group. With a pKa of 12.48, the guanidinium group is positively charged in neutral, acidic and even most basic environments, and thus imparts basic chemical properties to arginine. Because of the conjugation between the double bond and the lone pairs of nitrogen atoms, the positive charge is delocalized, enabling the formation of multiple hydrogen bonding, which prompts the binding with the HAP entity (rich of hydroxyl groups).
FN-III7–10 consists of four module domains and each is relatively independent. All modules and their different combinations were also analyzed with AutoDock, which suggested that FN-III10 is the most important one in the interaction with HAP, which can efficiently improve the interaction preference between the FN and HAP by optimizing their binding free energy (Figure 4). When combined with FN-III10, the lowest binding energy of FN-III9, FN-III8–9 and FN-III7–9 were decreased dramatically. In fact, short peptides containing the sequence motif Arg-Gly-Asp (RGD) from FN-III10 will bind to integrins themselves additional residues in FN-III9, the so-called synergy region, have also been implicated in this interaction . Thus, it is evident that mutual promotion is a common phenomenon in this system. The FN-III7, FN-III8 and FN-III9, however, are not able to enhance interaction affinity of HAP with other modules of the FN.
2.2. Analysis of HAP-Binding Site on RGD Loop
FN binding to the integrin receptors on most cells is modulated by interactions with a loop containing a RGD motif in the tenth FN-III module. Approximately one-third of the integrin receptor family recognizes RGD. The tripeptide itself improves the resistance of isolated islets against apoptosis . A distinct sequence in the ninth FN-III module (PHSRN in hFN-III9 and PPSRN in mFN-III9), the synergy region, is also implicated in the cell attachment interaction [23,24]. The cell-binding RGD loop itself is well-ordered, and extends 1 nm from the core of the molecule . Therefore, whether the binding of HAP to FN-III10 can interfere in the interaction between the RGD and integrin will be important for the biocompatibility of HAP.
Much attention has been paid on the binding sites of HAP on FN-III10 surface (Figure 5), and the amino acids involved in the interaction. Among all the binding sites, there are the lowest binding energy and most sites in cluster 1, where HAP is at the sides of RGD loop and the contacting residues are Ala1472, Lys1469 and Thr1473. The binding sites on cluster 2 are also at the sides of RGD loop, and the residues are Val1465, Lys1469 and Pro1466. Although binding sites in cluster 3 are nearby the RGD loop, but the interaction energy is higher, and the binding probability is the lowest. In a view, most the binding sites of HAP on FN-III are existed in the side region of RGD loop and does not directly interact with the residues in the loop (Arg1493, Gly1494 and Asp1495) to interfere the function of RGD in cell adhesion.
3.1. Setup of FN-III7–10 and HAP Structures
The high-resolution crystal structure (Figure 6) of FN-III7–10 was retrieved from the Protein Data Bank database with the access ID: 1FNF. The cell structure of HA [Ca9Na0.5(PO4)4.5(CO3)1.5(OH)2] (Figure 7) can easily accommodate a great variety of substitutes, including both anionic and cationic [26,27]. The compact arrangement of PO4 groups in the structure provides two kinds of channels containing calcium ions . Four per unit cell among them, called Ca I, are in columns parallel to the c-axis and surrounded by nine oxygen atoms [three O(1), three O(2) and three O(3)]. The others, six per unit cell, called Ca II, are surrounded by one O(1), one O(2), four O(3) and one OH ion. They form equilateral triangles centered at the unit-cell corners. The large size of the Ca II triangle allows motion of the hydroxyl ion along the column axis .
3.2. The FN-III7–10 Binding Site Prediction with MPK2
Meta Pocket 2.0 (MPK2) is a consensus method in which the pocket sites predicted by eight methods—LIGSITECS, PASS, Q-Site Finder, SURFNET, Fpocket, GHECOM, Con-Cavity and POCASA—are combined to improve the prediction success rate. There are three steps in the MPK2 procedure: calling-based methods, generating meta-pocket sites and mapping ligand-binding residues . Different PDB files (FN-III10, FN-III9–10, FN-III8–10 and FN-III7–10) were submitted one-by-one to the MPK2 web server  to perform an automatic site search. Then, only the top three pocket sites in each method are taken into further consideration. Therefore, we have a total of 24 pocket sites for each protein, which are clustered using a simple hierarchical clustering algorithm, according to their spatial similarity (distance based).
3.3. Performing Molecular Docking with AutoDock 4
Molecular docking is a computational method that predicts the binding of a ligand to a receptor . Hence, it is an important tool in studying receptor–ligand interactions . AutoDock is the most popular docking programs, which uses a Lamarckian genetic algorithm (LGA), but encompasses also a Monte Carlo simulated annealing and a traditional genetic algorithm, to position ligand binding modes within the active pocket of protein receptor. Simulated annealing issued for searching conformations, allowing several tensional degrees of freedom in a flexible ligand to be searched during the docking experiment, but with the limitation that it may not always find the global minimum conformation. A grid-based technique is used for energy evaluation at each step of the simulation, providing a detailed energetic model at reasonable computational cost. All the courses were done according to the protocol of AutoDock 4 .
FN-III10 is the most important module among FN-III7–10 in promoting fibronectin binding to HAP by optimizing the interaction energy; the arginine residues were observed to directly interact with the hydroxyl group of HAP through electrostatic forces and hydrogen bonding. The results verify that the HAP-binding sites on FN-III10 are mainly located at the RGD loop region, which does not affect the interaction between the fibronectin protein and its cognate receptors on the cell surface.
This work was supported by the National Basic Research Program of China (No. 2012CB933602), the National Natural Science Foundation of China (No. 51172188), the Science and Technology Pillar Project of Sichuan (No. 2010FZ0048), the Fundamental Research Funds for the Central Universities (Nos. 2682013CX034 and SWJTU11ZT25), and the SRTP of SWJTU (No. 201310613048).
Conflicts of Interest
The author declares no conflict of interest.
- Romberger, D.J. Fibronectin. Int. J. Biochem. Cell Biol. 1997, 29, 939–943.
- Brumfeld, V.; Werber, M. Studies on fibronectin and its domains: II. Secondary structure and spatial configuration of fibronectin and of its domains. Arch. Biochem. Biophys. 1993, 302, 134–143, doi:10.1006/abbi.1993.1191.
- Leahy, D.J.; Aukhil, I.; Erickson, H.P. 2.0 A crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region. Cell 1996, 84, 155–164, doi:10.1016/S0092-8674(00)81002-8.
- Hynes, R.O. Integrins: Bidirectional, allosteric signaling machines. Cell 2002, 110, 673–687, doi:10.1016/S0092-8674(02)00971-6.
- George, E.L.; Georges-Labouesse, E.N.; Patel-King, R.S.; Rayburn, H.; Hynes, R.O. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 1993, 119, 1079–1091.
- Pfaff, M.; McLane, M.A.; Beviglia, L.; Niewiarowski, S.; Timpl, R. Comparison of disintegrins with limited variation in the RGD loop in their binding to purified integrins αIIbβ3, αVβ3 and α5β1 and in cell adhesion inhibition. Cell Commun. Adh. 1994, 2, 491–501, doi:10.3109/15419069409014213.
- Dolatshahi-Pirouz, A.; Jensen, T.; Foss, M.; Chevallier, J.; Besenbacher, F. Enhanced surface activation of fibronectin upon adsorption on hydroxyapatite. Langmuir 2009, 25, 2971–2978, doi:10.1021/la803142u.
- Block, M.; Finger, I.; Fontenot, M.; Kent, J. Loaded hydroxylapatite-coated and grit-blasted titanium implants in dogs. Int. J. Oral Maxillofac. Implants 1989, 4, 219–225.
- Kasemo, B. Biological surface science. Surf. Sci. 2002, 500, 656–677, doi:10.1016/S0039-6028(01)01809-X.
- Holmberg, K. Novel Surfactants: Preparation Applications and Biodegradability, Revised and Expanded, 2nd ed. ed.; CRC Press: Boca Raton, FL, USA, 2003.
- Amaral, I.F.; Lamghari, M.; Sousa, S.R.; Sampaio, P.; Barbosa, M.A. Rat bone marrow stromal cell osteogenic differentiation and fibronectin adsorption on chitosan membranes: The effect of the degree of acetylation. J. Biomed. Mater. Res. A 2005, 75, 387–397.
- Cairns, M.L.; Meenan, B.J.; Burke, G.A.; Boyd, A.R. Influence of surface topography on osteoblast response to fibronectin coated calcium phosphate thin films. Colloids Surf. B Biointerfaces 2010, 78, 283–290, doi:10.1016/j.colsurfb.2010.03.013.
- Docheva, D.; Padula, D.; Schieker, M.; Clausen-Schaumann, H. Effect of collagen I and fibronectin on the adhesion, elasticity and cytoskeletal organization of prostate cancer cells. Biochem. Biophys. Res. Commun. 2010, 402, 361–366, doi:10.1016/j.bbrc.2010.10.034.
- Hindie, M.; Degat, M.C.; Gaudiere, F.; Gallet, O.; van Tassel, P.R.; Pauthe, E. Pre-osteoblasts on poly(l-lactic acid) and silicon oxide: Influence of fibronectin and albumin adsorption. Acta Biomater. 2011, 7, 387–394, doi:10.1016/j.actbio.2010.08.001.
- Geiger, B.; Bershadsky, A.; Pankov, R.; Yamada, K.M. Transmembrane crosstalk between the extracellular matrix and the cytoskeleton. Nat. Rev. Mol. Cell Biol. 2001, 2, 793–805, doi:10.1038/35099066.
- Wallwork, M.L.; Kirkham, J.; Zhang, J.; Smith, D.A.; Brookes, S.J.; Shore, R.C.; Wood, S.R.; Ryu, O.; Robinson, C. Binding of matrix proteins to developing enamel crystals: An atomic force microscopy study. Langmuir 2001, 17, 2508–2513.
- Kandori, K.; Murata, K.; Ishikawa, T. Microcalorimetric study of protein adsorption onto calcium hydroxyapatites. Langmuir 2007, 23, 2064–2070, doi:10.1021/la062562n.
- Gibson, J.M.; Popham, J.M.; Raghunathan, V.; Stayton, P.S.; Drobny, G.P. A solid-state NMR study of the dynamics and interactions of phenylalanine rings in a statherin fragment bound to hydroxyapatite crystals. J. Am. Chem. Soc. 2006, 128, 5364–5370, doi:10.1021/ja056731m.
- Vitorino, R.; Lobo, M.J.C.; Duarte, J.; Ferrer-Correia, A.J.; Tomer, K.B.; Dubin, J.R.; Domingues, P.M.; Amado, F.M.L. In vitro hydroxyapatite adsorbed salivary proteins. Biochem. Biophys. Res. Commun. 2004, 320, 342–346, doi:10.1016/j.bbrc.2004.05.169.
- Shen, J.W.; Wu, T.; Wang, Q.; Pan, H.H. Molecular simulation of protein adsorption and desorption on hydroxyapatite surfaces. Biomaterials 2008, 29, 513–532, doi:10.1016/j.biomaterials.2007.10.016.
- Huang, B. MetaPocket: A meta approach to improve protein ligand binding site prediction. OMICS 2009, 13, 325–330, doi:10.1089/omi.2009.0045.
- Lu, J.; Shi, M.; Shoichet, M.S. Click chemistry functionalized polymeric nanoparticles target corneal epithelial cells through RGD-cell surface receptors. Bioconjug. Chem. 2008, 20, 87–94.
- Aota, S.I.; Nomizu, M.; Yamada, K.M. The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesive function. J. Biol. Chem. 1994, 269, 24756–24761.
- Bowditch, R.D.; Hariharan, M.; Tominna, E.F.; Smith, J.W.; Yamada, K.M.; Getzoff, E.D.; Ginsberg, M.H. Identification of a novel integrin binding site in fibronectin. Differential utilization by beta 3 integrins. J. Biol. Chem. 1994, 269, 10856–10863.
- Riener, C.K.; Kienberger, F.; Hahn, C.D.; Buchinger, G.M.; Egwim, I.O.C.; Haselgrübler, T.; Ebner, A.; Romanin, C.; Klampfl, C.; Lackner, B.; et al. Heterobifunctional crosslinkers for tethering single ligand molecules to scanning probes. Anal. Chim. Acta 2003, 497, 101–114, doi:10.1016/j.aca.2003.08.041.
- Vignoles, M.; Bonel, G.; Holcomb, D.; Young, R. Influence of preparation conditions on the composition of type B carbonated hydroxyapatite and on the localization of the carbonate ions. Calcif. Tissue Int. 1988, 43, 33–40, doi:10.1007/BF02555165.
- Vignoles, M.; Bonel, G.; Young, R. Occurrence of nitrogenous species in precipitated B-type carbonated hydroxyapatites. Calcif. Tissue Int. 1987, 40, 64–70, doi:10.1007/BF02555707.
- Sudarsanan, K.T.; Young, R. Significant precision in crystal structural details. Holly Springs hydroxyapatite. Acta Crystallogr. B 1969, 25, 1534–1543, doi:10.1107/S0567740869004298.
- Feki, H.E.; Savariault, J.M.; Salah, A.B. Structure refinements by the Rietveld method of partially substituted hydroxyapatite: Ca9Na0.5(PO4)4.5(CO3)1.5(OH)2. J. Alloys Compd. 1999, 287, 114–120, doi:10.1016/S0925-8388(99)00070-5.
- Menendez-Proupin, E.; Cervantes-Rodriguez, S.; Osorio-Pulgar, R.; Franco-Cisterna, M.; Camacho-Montes, H.; Fuentes, M.E. Computer simulation of elastic constants of hydroxyapatite and fluorapatite. J. Mech. Behav. Biomed. Mater. 2011, 4, 1011–1020, doi:10.1016/j.jmbbm.2011.03.001.
- Zhang, Z.; Li, Y.; Lin, B.; Schroeder, M.; Huang, B. Identification of cavities on protein surface using multiple computational approaches for drug binding site prediction. Bioinformatics 2011, 27, 2083–2088, doi:10.1093/bioinformatics/btr331.
- MPK2 Home Page. Available online: http://projects.biotec.tu-dresden.de/metapocket/ (accessed on 16 December 2003).
- Sousa, S.F.; Fernandes, P.A.; Ramos, M.J. Protein-ligand docking: Current status and future challenges. Proteins 2006, 65, 15–26, doi:10.1002/prot.21082.
- Jiang, X.; Kumar, K.; Hu, X.; Wallqvist, A.; Reifman, J. DOVIS 2.0: An efficient and easy to use parallel virtual screening tool based on AutoDock 4.0. Chem. Cent. J. 2008, 2, 18, doi:10.1186/1752-153X-2-18.
- Morris, G.M.; Goodsell, D.S.; Halliday, R.S.; Huey, R.; Hart, W.E.; Belew, R.K.; Olson, A.J. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 1998, 19, 1639–1662, doi:10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B.
- Sample Availability: Not available.
© 2013 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).